Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 24.00
-1.00 (-4.00%)
Last updated: Jun 3, 2026, 7:55 PM CET
Immunocore Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 412.81 | 400.02 | 310.2 | 249.43 | 33.67 | 36.48 | |
Revenue Growth (YoY) | 23.75% | 28.95% | 24.37% | 640.71% | -7.70% | -11.39% |
Cost of Revenue | 4.69 | 5.09 | 2.73 | 1.04 | 1.09 | - |
Gross Profit | 408.12 | 394.93 | 307.47 | 248.39 | 32.59 | 36.48 |
Selling, General & Admin | 163.07 | 165.41 | 155.78 | 144.5 | 123.06 | 110.82 |
Research & Development | 279.51 | 274.87 | 222.15 | 163.55 | 101.92 | 100.25 |
Operating Income | -34.46 | -45.35 | -70.46 | -59.65 | -51.71 | -174.59 |
Interest Income | 15.72 | 16.48 | 25.62 | 17.99 | 3.76 | 0.07 |
Interest Expense | -12.19 | -12.17 | -18.84 | -5.15 | -5.41 | -5.57 |
Other Non-Operating Income (Expense) | 19.02 | 21.94 | 10.75 | -14.07 | 12.48 | 0.22 |
Total Non-Operating Income (Expense) | 22.55 | 26.25 | 17.52 | -1.24 | 10.83 | -5.29 |
Pretax Income | -11.91 | -19.1 | -52.94 | -60.89 | -40.88 | -179.88 |
Provision for Income Taxes | -15.65 | -16.41 | 1.85 | 5.6 | 11.66 | - |
Net Income | -27.57 | -2.69 | -54.79 | -66.49 | -52.54 | -180.03 |
Net Income to Common | -27.57 | -2.69 | -54.79 | -66.49 | -52.54 | -180.03 |
Shares Outstanding (Basic) | 50 | 50 | 50 | 49 | 46 | 42 |
Shares Outstanding (Diluted) | 51 | 50 | 50 | 49 | 46 | 42 |
Shares Change (YoY) | -0.35% | 0.71% | 2.25% | 6.94% | 7.59% | 60.19% |
EPS (Basic) | -0.54 | -0.71 | -1.02 | -1.13 | -1.15 | -4.24 |
EPS (Diluted) | -0.55 | -0.71 | -1.02 | -1.13 | -1.15 | -4.24 |
Shares Outstanding | 50.83 | 50.69 | 50.06 | 49.73 | 48.09 | 43.86 |
Free Cash Flow | -30.75 | -15.05 | 20.89 | -2.49 | -51.41 | -144.49 |
Free Cash Flow Per Share | -0.60 | -0.30 | 0.42 | -0.05 | -1.12 | -3.40 |
Gross Margin | 98.86% | 98.73% | 99.12% | 99.58% | 96.77% | 100.00% |
Operating Margin | -8.35% | -11.34% | -22.71% | -23.91% | -153.56% | -478.53% |
Profit Margin | 0.91% | -0.67% | -17.66% | -26.66% | -156.03% | -493.03% |
FCF Margin | -7.45% | -3.76% | 6.73% | -1.00% | -152.68% | -396.04% |
EBITDA | -31.89 | -42.09 | -66.26 | -55.56 | -46.37 | -167 |
EBITDA Margin | -7.73% | -10.52% | -21.36% | -22.27% | -137.71% | -457.72% |
EBIT | -34.46 | -45.35 | -70.46 | -59.65 | -51.71 | -174.59 |
EBIT Margin | -8.35% | -11.34% | -22.71% | -23.91% | -153.56% | -478.53% |
Effective Tax Rate | 131.41% | 85.94% | -3.49% | -9.20% | -28.52% | 0.00% |